From: Treatment adherence among new triptan users: a 2-year cohort study in Taiwan
Taiwan | US | UK | France | Germany | |
---|---|---|---|---|---|
Persistent users | 34.3 | 25.5 | 44.3 | 34.2 | 36.7 |
Within-class switchers | 0.01 | 7.4 | 4.9 | 6.8 | 6.3 |
Between-class switchers | 40.9 | 67.1 | 2.3 | 4.0 | 2.3 |
Opioids | 1.2 | 18.2 | 0.1 | 0 | 0 |
NSAIDs | 18.8 | 12.5 | 0.9 | 2.0 | 1.3 |
Barbiturates | 0 | 2.6 | 0 | 0 | 0 |
Ergot derivatives | 11.3 | 0 | 0.2 | 0.6 | 0.1 |
Discontinuers | 24.8 | 25.5 | 48.5 | 54.9 | 54.7 |
2-year retention rate | 4.0 | 6.4 | 13.0 | 6.0 | 9.0 |